Pacific Capital Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,000
Closed -$308K 60
2025
Q4
$308K Sell
5,000
-7,500
-60% -$459K 0.33% 35
2025
Q3
$780K Buy
12,500
+7,500
+150% +$522K 0.87% 28
2025
Q2
$399K Sell
5,000
-7,500
-60% -$627K 0.37% 40
2025
Q1
$1.07M Hold
12,500
0.68% 33
2024
Q4
$976K Hold
12,500
0.57% 41
2024
Q3
$901K Hold
12,500
0.53% 46
2024
Q2
$861K Buy
+12,500
New +$847K 0.57% 48

Other funds holding PBH

Pacific Capital Partners's PBH Position: Q1 2026 in Review

Pacific Capital Partners sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 5,000 shares — an estimated $308K sold.

Pacific Capital Partners first reported a position in PBH in Q2 2024 and held it in 7 quarters. The position peaked at $1.07M in Q1 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Pacific Capital Partners reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Pacific Capital Partners sold 5,000 Prestige Consumer Healthcare shares in Q1 2026, an estimated $308K.
  • Pacific Capital Partners first reported a position in Prestige Consumer Healthcare in Q2 2024 and held it in 7 quarters.
  • Pacific Capital Partners's Prestige Consumer Healthcare position peaked at $1.07M in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Pacific Capital Partners's 13F filing for Q1 2026, filed 9 Apr 2026.